InvestorsHub Logo
Followers 14
Posts 2297
Boards Moderated 0
Alias Born 12/20/2012

Re: To infinity and beyond! post# 238780

Wednesday, 08/29/2018 8:11:04 AM

Wednesday, August 29, 2018 8:11:04 AM

Post# of 403134
TIAB,

With headlines like their 5/9/18 concerning B-OM,¨Innovation Pharmaceuticals Concludes Data Analysis of its Phase 2 Clinical Trial for Severe Oral Mucositis in Head and Neck Cancer; Positioning to Fill a Substantial Void in Supportive Cancer Care¨ and this statement from same pr “Given the notable interest from global and specialty pharmaceutical companies that we have received following recent Brilacidin-OM data releases, we continue to carefully assess all of our potential alliance opportunities—toward cementing the best pathway forward,” said Leo Ehrlich, Chief Executive Officer of Innovation Pharmaceuticals. “The expedient advancement of Brilacidin-OM into later clinical development is a priority, as is the broader expansion of the complete Brilacidin Franchise.” leads one to beleive they didn´t lose too much interest.

Hopefully they have drawn up requests for proposals with all with the same scope (per indication) so as to expedite review and reduce alot of questions.

kfc


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News